Advocacy intelligence hub — real-time data for patient organizations
Institute of Hematology & Blood Diseases Hospital, China — PHASE2
Institute of Hematology & Blood Diseases Hospital, China
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome news →
View all Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome specialists →